A team combined AI protein structure prediction with high-throughput proteomics to discover molecular-glue degraders that target VAV1, a key immune-signaling protein, as reported by Hanfeng Lin et al. in Nature Communications in 2026.
A team at LMU Munich has developed SPARCS, which uses AI to analyze microscope images of 70 million cells at once and systematically screen how gene changes affect cells, as reported in Cell on October 8, 2026.
Anthropic says its Claude model helped discover a new enzyme system in bacteriophages, array-associated reverse transcriptases (ART), which feature CRISPR-like repeat arrays; 950 agents found it in 21 hours.
Illumina released SpliceAI2 on October 8, a genomic AI model that predicts how genetic variants alter RNA splicing, a key step in interpreting variants of uncertain significance.